Perimeter Solutions SA (PRM) SEC News Oct. 30, 2025, 11:56 UTC 5 1 comments (30% Negative) PERIMETER SOLUTIONS, INC. (PRM) Reports Q4 2025 Financial Results Comment Full text
Novo-Nordisk A/S (NONOF) SEC News Oct. 30, 2025, 11:39 UTC 5 1 comments (99% Neutral) Novo-Nordisk A/S (NONOF) Files Form 6-K Comment Full text
Westlake Chemical Corporation (WLK) SEC News Oct. 30, 2025, 11:33 UTC 4 1 comments (30% Negative) Westlake Corporation (WLK) Reports Q4 2025 Financial Results Comment Full text
Orchestra Biomed Holdings Inc (OBIO) SEC News Oct. 30, 2025, 11:30 UTC 5 1 comments (90% Positive) ORCHESTRA BIOMED HOLDINGS, INC. (OBIO) Announces Enrollment Update for sizes Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
iBio Inc. (IBIO) SEC News Oct. 30, 2025, 11:29 UTC 4 1 comments (70% Positive) iBio, Inc. (IBIO) Provides Update on potential for dosing as infrequently as twice per year Comment Full text
Foghorn Therapeutics Inc (FHTX) SEC News Oct. 30, 2025, 11:27 UTC 4 1 comments (90% Positive) Foghorn Therapeutics Inc. (FHTX) Files Form 8-K Comment Full text
Baxter International Inc (BAX) SEC News Oct. 30, 2025, 11:17 UTC 3 1 comments (10% Negative) Baxter International Inc. (BAX) Reports Q4 2025 Financial Results Comment Full text
NLS Pharmaceutics Ltd. (NLSPW) SEC News Oct. 30, 2025, 11:15 UTC 2 1 comments (19% Negative) NLS Pharmaceutics Ltd. (NLSPW) Announces Clinical Development Update (Form 6-K) Comment Full text
BioXcel Therapeutics Inc. (BTAI) SEC News Oct. 30, 2025, 11:15 UTC 6 1 comments (80% Positive) BioXcel Therapeutics, Inc. (BTAI) Announces Clinical Development Update Comment Full text
Cartesian Therapeutics Inc (RNAC) SEC News Oct. 30, 2025, 11:10 UTC 6 1 comments (10% Negative) CARTESIAN THERAPEUTICS, INC. (RNAC) Announces Delay in instrumental Trials for autoimmune diseases Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review Comment Full text